Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

de Leon J, Armstrong SC, Cozza KL.

Psychosomatics. 2006 Jan-Feb;47(1):75-85. Review.

PMID:
16384813
2.

The AmpliChip CYP450 genotyping test: Integrating a new clinical tool.

de Leon J, Susce MT, Murray-Carmichael E.

Mol Diagn Ther. 2006;10(3):135-51. Review.

PMID:
16771600
3.

AmpliChip CYP450 test: personalized medicine has arrived in psychiatry.

de Leon J.

Expert Rev Mol Diagn. 2006 May;6(3):277-86. Review.

PMID:
16706732
4.

Clinical applications of CYP genotyping in psychiatry.

Spina E, de Leon J.

J Neural Transm (Vienna). 2015 Jan;122(1):5-28. doi: 10.1007/s00702-014-1300-5. Epub 2014 Sep 9. Review.

PMID:
25200585
5.

Applications of CYP450 testing in the clinical setting.

Samer CF, Lorenzini KI, Rollason V, Daali Y, Desmeules JA.

Mol Diagn Ther. 2013 Jun;17(3):165-84. doi: 10.1007/s40291-013-0028-5. Review.

6.
7.

Pharmacogenetics and psychopharmacotherapy.

Poolsup N, Li Wan Po A, Knight TL.

J Clin Pharm Ther. 2000 Jun;25(3):197-220. Review.

PMID:
10886465
8.

Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Desta Z, Zhao X, Shin JG, Flockhart DA.

Clin Pharmacokinet. 2002;41(12):913-58. Review.

PMID:
12222994
10.

Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Zhou SF.

Clin Pharmacokinet. 2009;48(11):689-723. doi: 10.2165/11318030-000000000-00000. Review.

PMID:
19817501
11.

Towards the implementation of CYP2D6 and CYP2C19 genotypes in clinical practice: update and report from a pharmacogenetic service clinic.

Müller DJ, Kekin I, Kao AC, Brandl EJ.

Int Rev Psychiatry. 2013 Oct;25(5):554-71. doi: 10.3109/09540261.2013.838944. Review.

PMID:
24151801
12.

Pharmacogenetics of antidepressant drugs: State of the art and clinical implementation - recommendations from the French National Network of Pharmacogenetics.

Quaranta S, Dupouey J, Colle R, Verstuyft C.

Therapie. 2017 Apr;72(2):311-318. doi: 10.1016/j.therap.2016.09.018. Epub 2017 Jan 30. Review.

PMID:
28237405
13.

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, Skaar TC, Müller DJ, Gaedigk A, Stingl JC; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2013 May;93(5):402-8. doi: 10.1038/clpt.2013.2. Epub 2013 Jan 16. Review.

14.

Implementation of CYP2D6 genotyping in psychiatry.

Loovers HM, van der Weide J.

Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1065-77. doi: 10.1517/17425250903081738. Review.

PMID:
19572825
15.

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.

Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, Brockmöller J.

Mol Psychiatry. 2004 May;9(5):442-73. Review.

PMID:
15037866
16.

Pharmacogenetics and drug therapy in psychiatry--the role of the CYP2D6 polymorphism.

Vandel P, Talon JM, Haffen E, Sechter D.

Curr Pharm Des. 2007;13(2):241-50. Review.

PMID:
17269931
17.

Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).

Matchar DB, Thakur ME, Grossman I, McCrory DC, Orlando LA, Steffens DC, Goldstein DB, Cline KE, Gray RN.

Evid Rep Technol Assess (Full Rep). 2007 Jan;(146):1-77. Review.

18.

Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics.

Cacabelos R, Llovo R, Fraile C, Fernández-Novoa L.

Curr Alzheimer Res. 2007 Sep;4(4):479-500. Review.

PMID:
17908053
19.

Imipramine Therapy and CYP2D6 and CYP2C19 Genotype.

Dean L.

In: Pratt V, McLeod H, Dean L, Malheiro A, Rubinstein W, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-.
2017 Mar 23.

20.

Supplemental Content

Support Center